Rhythm Pharmaceuticals
RYTM
RYTM
80 hedge funds and large institutions have $621M invested in Rhythm Pharmaceuticals in 2020 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 28 increasing their positions, 21 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
36% less capital invested
Capital invested by funds: $973M → $621M (-$352M)
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
95% less call options, than puts
Call options by funds: $1K | Put options by funds: $19K
Holders
80
Holding in Top 10
2
Calls
$1K
Puts
$19K
Top Buyers
| 1 | +$22.1M | |
| 2 | +$4.21M | |
| 3 | +$2.36M | |
| 4 |
Aviva
London,
United Kingdom
|
+$2.02M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$1.64M |
Top Sellers
| 1 | -$19.2M | |
| 2 | -$19.1M | |
| 3 | -$12.2M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$9.93M |
| 5 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$2.54M |